Abzena plc

Sr Principal Scientist, Conjugation Process Development

Abzena plc$120K — $150K *
Pharmaceuticals & Biotech
8 - 10 years of experience
Job Overview by Ladders

Qualifications

  • Ph.D. in Chemistry, Chemical Engineering, or related field with 10+ years of industry experience, or M.S. with 12+ years.
  • Extensive experience in bioconjugation process development for ADCs or related therapeutics.
  • Strong grasp of conjugation chemistry and linker-payload technologies.
  • Demonstrated experience in CGMP manufacturing and technology transfer.
  • Working knowledge of CMC development principles and regulatory expectations.
  • Experience with statistical experimental design (DOE) methodologies.
  • Proven ability to lead complex technical programs independently.

Responsibilities

  • Lead development and optimization of conjugation chemistry processes for bioconjugates.
  • Design scalable and manufacturable conjugation strategies focusing on robustness and product quality.
  • Develop and execute DOE campaigns and scale-up strategies for clinical manufacturing.
  • Act as a subject matter expert for conjugation chemistry and process controls.
  • Collaborate on establishing critical quality attributes and in-process controls with analytical teams.
  • Author and review technical documents and regulatory submissions.
  • Provide technical oversight during CGMP manufacturing campaigns and troubleshoot process deviations.

Benefits

  • Opportunity to work on cutting-edge conjugate therapeutics including ADCs and AOCs.
  • Engagement in cross-functional collaboration with multiple key departments.
  • Role includes mentorship and leadership opportunities for junior scientists.
  • Participation in continuous improvement initiatives for process efficiency.
  • Exposure to senior leadership through presentation of technical updates and strategies.
Full Job Description
We are seeking a highly motivated and experienced Principal Scientist to drive conjugation process development activities supporting bioconjugates, including antibody-drug conjugates (ADCs), oligonucleotide conjugates (AOCs, ARCs, etc.), and other conjugate therapeutics. This individual will serve as a technical leader responsible for developing robust, scalable, and phase-appropriate conjugation processes from early development through commercial readiness.

The successful candidate will provide scientific leadership across process chemistry, analytical characterization, technology transfer, manufacturing support, and regulatory documentation while collaborating closely with CMC, analytical, manufacturing, quality, and project management teams.

Responsibilities

  • Lead development and optimization of conjugation chemistry processes for bioconjugates, including ADCs and other linker-payload platforms.
  • Design scalable and manufacturable conjugation strategies with a focus on process robustness, product quality, yield, and reproducibility.
  • Develop and execute DOE campaigns, and scale-up strategies for clinical manufacturing.
  • Serve as subject matter expert (SME) for conjugation chemistry, analytical characterization of conjugation processes, and process controls.
  • Collaborate with analytical development teams to establish critical quality attributes (CQAs), in-process controls, and release specifications.
  • Author and review technical reports, development summaries, batch records, SOPs, regulatory sections (IND/BLA/IMPD), and technology transfer documentation.
  • Provide technical oversight during CGMP manufacturing campaigns as needed.
  • Troubleshoot process deviations, investigations, and manufacturing challenges related to conjugation operations.
  • Drive implementation of platform technologies and continuous improvement initiatives to enhance process efficiency and scalability.
  • Mentor junior scientists and contribute to scientific strategy, innovation initiatives, and cross-functional technical leadership.
  • Present development updates and technical recommendations to senior leadership and client project teams.Qu


Required Qualifications

  • Ph.D. in Chemistry, Chemical Engineering, Pharmaceutical Sciences, or related scientific discipline with 10+ years of relevant industry experience; or M.S. with 12+ years of industry experience.
  • Extensive experience in bioconjugation process development, particularly ADCs or related targeted therapeutics.
  • Strong understanding of conjugation chemistries, linker-payload technologies, purification methods, and protein/conjugate characterization.
  • Demonstrated experience supporting CGMP manufacturing and technology transfer activities.
  • Working knowledge of CMC development principles, regulatory expectations, and phase-appropriate development strategies.
  • Experience with statistical experimental design (DOE) and process characterization methodologies.
  • Proven ability to independently lead complex technical programs in a fast-paced environment.


Preferred Qualifications

  • Experience with site-specific conjugation technologies and next-generation ADC platforms.
  • Familiarity with high-potency compound handling and containment operations.
  • Experience presenting development findings externally to client sponsors.
  • Knowledge of analytical methods including HIC, SEC, LC-MS, CE-SDS, and DAR characterization.
  • Prior experience supporting late-stage or commercial process validation activities.


FLSA: Exempt

About Abzena plc

Abzena is a life sciences group with headquarters in Cambridge, UK and offices in the US and Japan. The company provides technologies and complementary services to enable the development and manufacture of biopharmaceutical products. Abzena's services and technologies are used by a range of companies and academic organisations across the pharmaceutical industry, including small biotech to large pharmaceutical companies. The company's proprietary technologies include composite human antibodies and site-specific conjugation technologies, which enable the development of antibody drug conjugates (ADCs) and other biotherapeutics. Abzena's services include antibody discovery and engineering, immunology services, bioassays, cell line development, and biomanufacturing. The company has a range of partnerships and collaborations with pharmaceutical companies and academic institutions, and has a number of products in clinical development.
Learn more about Abzena plc
Size
200 employees
Industry
Founded
2014
Revenue
$17 million
NASDAQ

Similar Jobs

More Jobs at Abzena plc

More Pharmaceuticals & Biotech Jobs

Find similar Sr Principal Scientist, Conjugation Process Development jobs: